RecruitingPhase 1ketamine

A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

Sponsored by Juliana Zambrano, MD, MPH

NCT ID
NCT06597695
Target Enrollment
10 participants
Start Date
2025-07-23
Est. Completion
2026-07-01

About This Study

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

Conditions Studied

Depression

Interventions

  • Ketamine-assisted psychotherapy

Eligibility

Age:18 Years - 64 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1\. Self-identifying Latinx, Spanish-speaking 2. Adults 18-64 years 3. Meet DSM-5 criteria for major depressive disorder as evaluated by study clinician 4. Montgomery-Asberg depression scale (MADRS) score of 20 or above at baseline 4. Participants must have an MGB psychiatrist and primary care provider.

Exclusion Criteria:

1. History of primary psychotic disorder, by history
2. History Bipolar I disorder, by history
3. Unstable complex PTSD, as assessed by study clinician
4. History of dissociative identity disorder
5. History of neurocognitive disorder
6. History of severe and/or recent substance use disorder, by history and as assessed by study clinician after clinical evaluation and interview
7. Uncontrolled hypertension, tachycardia, or unstable cardiopulmonary disease, by history a. Blood pressure on initial screen must be \<140/90 mmHg.
8. History of aortic dissection
9. History of myocardial infarction
10. History of aneurysm
11. History of hepatic impairment.
12. History of epilepsy
13. History of prior hypersensitivity to ketamine
14. Body Mass Index greater than 35
15. Body Mass Index less than 18.5
16. Are pregnant, breastfeeding, or planning to become pregnant within 12 weeks of treatment completion
17. Enrolled in other clinical trial for the treatment of depression or other behavioral health diagnosis
18. Inability to provide consent.

Study Locations (1)

Massachusetts General Hospital, Chelsea
Chelsea, Massachusetts, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Juliana Zambrano, MD
CONTACT
617-726-2000JZAMBRANO2@mgh.harvard.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source